Atlas Trials

A Study To Evaluate The Safety And Efficacy Of PF-04958242 In Subjects With Cognitive Impairment Associated With Schizophrenia (CIAS)

Clinical trial NCT02855411 · TERMINATED

Trial details

NCT number
NCT02855411
Sponsor
Biogen
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Cognitive Impairment Associated With Schizophrenia (CIAS)
Start date
2016-08-29
Primary completion
2016-09-26
Enrollment
35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.